Finerenone Demonstrates Wide-Ranging Benefits for Chronic Kidney Disease Patients

New research, published across multiple prestigious medical journals, indicates that finerenone provides significant kidney and heart protection for a broader spectrum of chronic kidney disease (CKD) patients than previously understood. A comprehensive analysis of nearly 15,000 participants, including those without diabetes, revealed that the drug reduced the risk of kidney failure, cardiovascular events, and all-cause mortality.